超声引导高强度聚焦超声消融治疗多发性子宫肌瘤女性的疗效与安全性:一项探索性研究
该探索性研究纳入138例多发性子宫肌瘤患者(A组,其中125例有2至4个肌瘤、13例有5个及以上肌瘤)和149例单发性子宫肌瘤患者(B组),比较超声引导高强度聚焦超声(USg-HIFU)治疗的疗效与安全性。结果显示两组术后症状评分和肌瘤体积均较术前明显改善(所有P值<0.001),但A组达到70%无灌注体积比需要更多能量和更长治疗及辐照时间,能量效率因子低于B组(所有P值<0.05)。A组建立列线图模型纳入肌瘤体积、位置和T2加权成像信号强度,曲线下面积和准确率分别为0.698和0.686。
要点
- 多发性子宫肌瘤USg-HIFU术后症状评分和肌瘤体积较术前明显改善(所有P值<0.001)。
- A组达到70%无灌注体积比所需能量更多、治疗和辐照时间更长,能量效率因子低于B组(所有P值<0.05)。
- 列线图模型纳入肌瘤体积、位置和T2WI信号强度,AUC与准确率分别为0.698和0.686。
核心结论
- USg-HIFU似乎对多发性子宫肌瘤是一种有效且安全的治疗选择;了解肌瘤体积、位置和T2WI信号强度可能有助于判定USg-HIFU在多发性子宫肌瘤中的疗效。
研究设计与样本
- 探索性研究,纳入138例多发性子宫肌瘤患者(A组,其中125例有2至4个肌瘤、13例有5个及以上肌瘤)和149例单发性子宫肌瘤患者(B组),记录HIFU治疗信息、疗效比较和不良事件,建立预测USg-HIFU疗效的特征参数列线图模型。
关键影像表现/征象
- USg-HIFU治疗后,两组术前与术后症状评分和肌瘤体积的统计比较均显示症状明显缓解和肌瘤体积显著缩小(所有P值<0.001)。
- A组达到70%无灌注体积比需要更多能量、更长治疗时间和辐照时间,且能量效率因子低于B组(所有P值<0.05)。
- 两组均未观察到严重并发症。
- 列线图模型纳入肌瘤体积、肌瘤位置和T2加权成像信号强度。
诊断标准与关键数值
- 列线图模型预测USg-HIFU治疗多发性子宫肌瘤疗效的受试者工作特征曲线下面积为0.698,准确率为0.686。
- A组达到70%无灌注体积比所需能量更多、治疗和辐照时间更长,能量效率因子低于B组(所有P值<0.05)。
临床应用与阅片要点
- 了解肌瘤体积、位置和T2WI信号强度可能有助于判断USg-HIFU治疗多发性子宫肌瘤的疗效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of the work described here was to explore the clinical efficacy and safety of ultrasound-guided high-intensity focused ultrasound (USg-HIFU) treatment in women with multiple fibroids and identify the characteristic parameters predicting USg-HIFU efficacy in multiple fibroids.
METHODS: From February 2021 to August 2022, 138 patients with multiple fibroids (group A comprising 125 patients with two to four fibroids and 13 patients with five or more fibroids) and 149 patients with solitary fibroids (group B) were included. HIFU treatment information, efficacy comparisons and adverse events were recorded. A nomogram model of the characteristic parameters used to predict the efficacy of USg-HIFU in multiple fibroids was established.
RESULTS: After USg-HIFU treatment, the statistical comparison of pre-operative versus post-operative symptom scores and fibroid volume in the two groups indicated obvious symptom relief and substantial shrinkage of fibroid volume (all p values <0.001). Nevertheless, group A required more energy and longer treatment and sonication times to achieve a 70% non-perfused volume (NPV) ratio, and had a lower energy efficiency factor than group B (all p values <0.05). No severe complications were observed in either group. The nomogram model included fibroid volume, fibroid location and signal intensity on T2-weighted imaging (T2WI). The area under the receiver operating characteristic curve and the accuracy of the model were 0.698 and 0.686, respectively.
CONCLUSION: USg-HIFU appears to be an effective and safe treatment option for multiple fibroids. Knowledge of the fibroid volume, location and signal intensity on T2WI may help determine the efficacy of USg-HIFU in multiple fibroids.
引用
- Shi L, Zhang R, Tao S, et al. Efficacy and Safety of Ultrasound-Guided High-Intensity Focused Ultrasound Ablation in Women With Multiple Uterine Fibroids: An Exploratory Study. Ultrasound Med Biol. 2023. PMID: 37596155. doi:10.1016/j.ultrasmedbio.2023.08.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。